Ovid’s Patient-Driven Approach to the Rapid Development of Meaningful Medicines for Neurodevelopmental Disorders

Time: 5:30 pm
day: Day One


  • Working with rare disease stakeholders to forge efficient collaborations that will positively impact patients
  • Community-powered approaches to boost enrollment & the overall availability of data
  • Ovid’s approach to developing endpoints that are patient-centric
  • Driving effective rare disease policy, access to diagnostics and inclusive education